Ask VialBase
cognitive

Cerebrolysin

FDA: not-FDA-approved

Cerebrolysin is a neuropeptide blend derived from pig brain proteins containing low-molecular-weight peptides and free amino acids that cross the blood-brain barrier. It is used extensively in Europe and Asia for neurodegenerative conditions, traumatic brain injury, and stroke recovery. Randomized controlled trial evidence supports improved clinical outcomes in vascular dementia (PMID: 20656516). Contains growth factors that nourish the brain. Promotes neurogenesis, inhibits apoptosis, and supports synaptic plasticity. Supports neuroprotection, synaptic repair, and reduces glial overactivation. Calms CNS, rebuilds damaged pathways, and helps erase "ghost" pain patterns stored in the brain. Supports hippocampal function and cognitive plasticity. - Brain injury and

This content is for educational and research purposes only. VialBase does not provide medical advice. Consult a healthcare professional before using any peptide.

Molecular weight —
Half-life —
CAS number —
Route —

Stacks containing Cerebrolysin

Brain Blitz

Semax + Dihexa + Cerebrolysin

Executive Function

Semax + Cerebrolysin + Selank

28-day resets featuring Cerebrolysin

What bloodwork do I need?

Reference ranges are general guidelines. Consult your physician for interpretation.

PRE-CYCLE
  • CMP
  • CBC
  • CRP
DURING CYCLE
  • CMP
  • CRP
POST-CYCLE
  • CMP
  • CBC
Safety & Regulatory Status
FDA STATUS not-FDA-approved

Regulatory status for Cerebrolysin may change. Verify current status with your jurisdiction before use. This is not legal or medical advice.

Frequently Asked Questions

What is Cerebrolysin?
Cerebrolysin is a neuropeptide blend derived from pig brain proteins containing low-molecular-weight peptides and free amino acids that cross the blood-brain barrier. It is used extensively in Europe and Asia for neurodegenerative conditions, traumatic brain injury, and stroke recovery.
How does Cerebrolysin work?
Contains growth factors that nourish the brain. Promotes neurogenesis, inhibits apoptosis, and supports synaptic plasticity. Supports neuroprotection, synaptic repair, and reduces glial overactivation.
How is Cerebrolysin dosed?
Standard: 5 ml IM daily or every other day (most common); Cycle: 10-20 days; up to 30 days for TBI; Maintenance: 5 ml IM 2x/week; Route: Intramuscular (IM) injection; IV also used clinically. These figures reflect commonly cited research protocols, not medical advice — consult a clinician.
Is Cerebrolysin FDA-approved?
Cerebrolysin is not FDA-approved. Not FDA-approved in the United States; Widely studied and used internationally — approved in many countries outside the US; Approved in Russia and Eastern Europe for clinical use; Available through international pharmacies and research suppliers.